Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 343-350

  Skeie, Geir Olve ^a,b   Romi, Fredrik ^a   Aarli, Johan A ^a   Bentsen, Pål Tore ^a   Gilhus, Nils Erik ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acetylcholine receptor; Antibodies; Myasthenia gravis; Ryanodine receptor; Titin

Indexed keywords

CONNECTIN; MUSCLE PROTEIN; RECEPTOR ANTIBODY; RYANODINE; RYANODINE RECEPTOR;

CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE SEVERITY; ELECTROPHYSIOLOGY; EXCITATION CONTRACTION COUPLING; HUMAN; IN VITRO STUDY; MUSCLE DEVELOPMENT; MUSCLE FUNCTION; MYASTHENIA GRAVIS; MYOPATHY; MYOSITIS; SARCOPLASMIC RETICULUM; THYMOMA;

EID: 0141839032     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.039     Document Type: Conference Paper

References (40)

1. LINDSTROM, J., D. SCHELTON & Y. FUJII. 1988. Myasthenia gravis. Adv. Immunol. 42: 233-284.
2. NIELSEN, V.K., O.B. PAULSON, J. ROSENKVIST et al. 1982. Rapid improvement of myasthenia gravis after plasma exchange. Ann. Neurol. 11: 160-169.
3. PAGALA, M., N.V. NANDAKUMAR, S.A.T. VENKATACHARI et al. 1990. Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis. Muscle Nerve 13: 1012-1022.
4. PAGALA, M., N.V. NANDAKUMAR, S.A.T. VENKATACHARI et al. 1993. Mechanisms of fatigue in normal intercostal muscle and muscle from patients with myasthenia gravis. Muscle Nerve 16: 911-921.
5. SOMNIER, F.E., G.O. SKEIE, J.A. AARLI et al. 1999. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis. Eur. J. Neurol. 6: 1-9.
6. AARLI, J.A. 1998. Inflammatory myopathy in myasthenia gravis. Curr. Opin. Neurol. 11: 233-234.
7. STRAUSS, A.J.L. & P.G. KEMP. 1967. Serum autoantibodies in myasthenia gravis and thymoma: selective affinity for I-bands of striated muscle as a guide to identification of antigen(s). J. Immunol. 99: 945-953.
8. AARLI, J.A., K. STEFANSSON, L.S.G. MARION et al. 1990. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin. Exp. Immunol. 82: 284-288.
9. MYGLAND, Å., O.B. TYSNES, R. MATRE et al. 1992. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann. Neurol. 32: 589-591.
10. ALARCON-SEGOVIA, D., A. RUIZ-ARGUELLES & L. LLORENTE. 1996. Broken dogma: penetration of autoantibodies into living cells. Immunol. Today 17: 163-164.
11. BEUTNER, E.H., G. FAZEKAS, A. SCOTT et al. 1966. Direct fluorescent antibody studies of gamma globulin localization in muscle of patients with myasthenia gravis. Ann. N.Y. Acad. Sci. 135: 588-600.
12. LABEIT, S. & B. KOLMERER. 1995. Titins: giant proteins in charge of muscle ultrastructure and elasticity. Science 270: 293-296.
13. FURST, D.O., M. OSBORN, R. NAVE et al. 1988. The organization of titin filaments in the half-sarcomere revealed by monoclonal antibodies in immunoelectron microscopy: a map of ten non-repetitive epitopes starting at the Z-line extends close to the M-line. J. Cell Biol. 106: 1563-1572.
14. LINKE, W., D.E. RUDY, T. CENTNER et al. 1999. I-band titin in cardiac muscle is a three-element molecular spring and is critical for maintaining thin filament structure. J. Cell Biol. 146: 631-644.
15. MARSZALEK, P.I., H. LU, H. LI et al. 1999. Mechanical unfolding intermediates in titin modules. Nature 402: 100-103.
16. GAUTEL, M., A. LAKEY, P.D. BARLOW et al. 1993. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 43: 1581-1585.
17. LUEBKE, E., A. FREIBURG, G.O. SKEIE et al. 1998. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes. J. Neuroimmunol. 81: 98-108.
18. WILLIAMS, C.L., J.E. HAY, T.W. HUIATT et al. 1992. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin. Lab. Invest. 66: 331-336.
19. SKEIE, G.O., Å. MYGLAND, J.A AARLI et al. 1995. Titin antibodies in patients with late-onset myasthenia gravis: clinical correlations. Autoimmunity 20: 99-105.
20. SKEIE, G.O., J.A. AARLI, R. MATRE et al. 1997. Titin antibody positive myasthenia gravis patients have a cellular immune response against the main immunogenic region of titin. Eur. J. Neurol. 4: 131-137.
21. SKEIE, G.O., P.T. BENTSEN, A. FREIBURG et al. 1998. Cell mediated immune response against titin in myasthenia gravis: evidence for the involvement of Th1 and Th2 cells. Scand. J. Immunol. 47: 76-81.
22. CORONADO, R., J. MORRISSETTE, M. SUKHAREVA et al. 1994. Structure and function of ryanodine receptors. Am. J. Physiol. 266: c1485-c1504.
23. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 265: 2244-2256.
24. TAKESHIMA, H., S. NISHIMURA, T. MATSUMOTO et al. 1989. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339: 439-445.
25. INUI, M., A. SAITO & S. FLEISCHER. 1987 Isolation of the ryanodine receptor from cardiac sarcoplasmic reticulum and identity with the feet structures. J. Biol. Chem. 262: 15637-15642.
26. TAKESHIMA, H., I. MASAMITSU, H. TAKEKURA et al. 1994. Excitation-contraction uncoupling in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 369: 556-559.
27. TANABE, T., K. BEAN, B.A. ADAMS et al. 1990. Region of the skeletal muscle dihydropyridine receptor critical for excitation-contraction coupling. Nature 346: 567-569.
28. MYGLAND, Å., O.B. TYSNES, R. MATRE et al. 1994 Anti-cardiac ryanodine receptor antibodies in thymoma associated myasthenia gravis. Autoimmunity 17: 327-331.
29. MYGLAND, Å., J.A. AARLI, R. MATRE et al., 1994. Ryanodine receptor antibodies related to severity of thymoma-associated myasthenia gravis. J. Neurol. Neurosurg. Psychiatry 57: 843-846.
30. MYGLAND, Å., O.B. TYSNES, J.A. AARLI et al. 1993. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma. J. Autoimmun. 6: 507-515.
31. ROMI, F., G.O. SKEIE, J.A. AARLI et al. 2000. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis: a study of IgG subclasses and clinical correlation. J. Neuroimmunol. 111: 169-176.
32. 3H]-ryanodine to sarcoplasmic reticulum. Muscle Nerve 21: 329-335.
33. SKEIE, G.O., Å. MYGLAND, S. TREVES et al. 2003. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle Nerve 27: 81-89.
34. LEONG, P. & D.H. MACLENNAN. 1998. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor. J. Biol. Chem. 273: 7791-7794.
35. LEONG, P. & D.H. MACLENNAN. 1998. The cytoplasmic loops between domains II and III and domains III and IV in the skeletal muscle dihydropyridine receptor bind to a contiguous site in the skeletal muscle ryanodine receptor. J. Biol. Chem. 273: 29958-29964.
36. IWASA, K., K. KOMAI & M. TAKAMORI. 1998. Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies. Muscle Nerve 21: 1655-1660.
37. VOLTZ, R.D., W.C. ALBRICH, A. NAGELE et al. 1997. Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology 49: 1454-1457.
38. ROMI, F., G.O. SKEIU, J.A. AARLI et al. 2000. Muscle autoantibodies in subgroups of myasthenia gravis patients. J. Neurol. 247: 369-375.
39. SKEIE, G.O., E. BARTOCCIONI, A. EVOLI et al. 1996. Ryanodine receptor antibodies are associated with severe myasthenia gravis. Eur. J. Neurol. 3: 136-140.
40. ROMI, F., N.E. GILHUS, J.E. VARHAUG et al. 2002. Thymectomy vs. non-thymectomy in late-onset myasthenia gravis in correlation with muscle autoantibodies. Eur. J. Neurol. 9: 55-61.